Abstract
Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the management of aggressive hematologic malignancies. However, its role in patients with lymphoma and cardiac metastasis or cardiomyopathy remains undefined due to potentially life-threatening complications such as ventricular rupture, cardiac tamponade, and circulatory failure. We present a case series of patients with lymphoma and cardiomyopathy or cardiac metastasis managed with chimeric antigen receptor T-cell therapy. (Level of Difficulty: Advanced.)
Original language | English (US) |
---|---|
Article number | 101840 |
Journal | JACC: Case Reports |
Volume | 15 |
DOIs | |
State | Published - Jun 7 2023 |
Keywords
- CAR-T
- cardiac
- cardio-oncology
- cardiomyopathy
- lymphoma
- metastasis
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine